Sign in

Metastatic breast cancer trials, also abroad

684 open Metastatic breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
China224
United States222
France83
Spain73
Italy70
All other countries

The same trial often runs in several countries

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer has 5 sites in Thailand and runs in 29 countries. If a site near you is full, another one may still take people.

See Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer in all 29 countries